J Hammarsten

Summary

Country: Sweden

Publications

  1. doi request reprint Urological aspects of the metabolic syndrome
    Jan Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Rosenborgsgatan 2, S 652 30 Karlstad, Sweden
    Nat Rev Urol 8:483-94. 2011
  2. doi request reprint A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer
    J Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Karlstad, Sweden
    Cancer Epidemiol 34:574-9. 2010
  3. ncbi request reprint Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, Halmstad, Sweden
    Blood Press 13:47-55. 2004
  4. ncbi request reprint Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, SE 30185 Halmstad, Sweden
    Eur J Cancer 41:2887-95. 2005
  5. doi request reprint Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
    J Hammarsten
    Department of Urology, Skaraborg Hospital, Skovde, Sweden
    Prostate Cancer Prostatic Dis 12:160-5. 2009
  6. ncbi request reprint Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Halland, Varberg Hospital, Varberg, Sweden
    Scand J Urol Nephrol 36:330-8. 2002
  7. ncbi request reprint Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia
    J Hammarsten
    Urological Section, Department of Surgery, Varberg Hospital, Varberg, Sweden
    Eur Urol 39:151-8. 2001
  8. doi request reprint One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms
    Johan Stranne
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 43:199-205. 2009
  9. doi request reprint Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
    Per Olov Hedlund
    Department of Urology, Karolinska University Hospital Solna, Sweden
    Scand J Urol Nephrol 42:220-9. 2008
  10. ncbi request reprint Preoperative skin testing of materials used in surgical procedures
    Rosalie Hammarsten
    Central Operating Department, Varberg Hospital, Sweden
    AORN J 77:762-6, 769-71. 2003

Collaborators

  • Jan Erik Damber
  • U Smith
  • C Ohlsson
  • M Karlsson
  • Angelique Flöter Rådestad
  • Eberhard Varenhorst
  • J Stranne
  • F Rasmussen
  • Peter Iversen
  • Par Stattin
  • Lena Damber
  • Hans H Hedelin
  • T L J Tammela
  • Per Olov Hedlund
  • Rosalie Hammarsten
  • Harri Juusela
  • Eero Kasinen
  • Ilker Tasdemir
  • Bo Hedberg
  • Bengt Hahne
  • Jesper Rue Andersen
  • Björn Kihl
  • Carl Johan Ribbegren
  • Gudmundur Geirsson
  • Arne Höjsgaard
  • John Farber
  • Peter Klarskov
  • Andrzej Owczarski
  • Mauritz Wallden
  • Peter Mogensen
  • Paul Skaarup
  • Martti Talja
  • Inger Wall
  • Jaakko Permi
  • Hans Georg Iversen
  • Hans Wolf
  • Sture Carlsson
  • Richard Ideström
  • Inger Hagerman
  • Sven Olof Andersson
  • Sakari Rannikko
  • Rolf Lundgren
  • Inge Höjgaard
  • Peter Elfving
  • Valdemar Hvidt
  • Lars Häggarth
  • Leif Borck
  • Per Ogreid
  • Peter Henriksson
  • Ebbe Telhammar
  • Jaakko Salo
  • Veli Matti Puolakka
  • Torsten Lindeborg
  • Ole Sorensen
  • Svein Haukaas
  • Antero Halme
  • Reinhard Stege
  • Palle Rosenkilde
  • Per Lundmo
  • Ronnie Olsson
  • Martti Ala Opas
  • Agneta Ullman
  • Einar Brekkan
  • Jan Erik Johansson
  • Fredrik Hesselberg
  • Mirja Ruutu
  • Lars Adell
  • Ib Mikkelsen
  • Sören Mommsen
  • Robert Johansson
  • Erkki Hansson
  • Tapani Liukkonen
  • Jan Olof Olsson
  • Ole Srensen
  • Per Aage Hoisaeter
  • Curt Erik Nelson
  • Ake Pousette
  • Jouko Viitanen
  • Anders Spangberg
  • Torsten Sandin
  • Svend Mortensen
  • Jörgen Kvist Kristensen
  • Bengt Andersson
  • Finn Lundbeck
  • Sigmund Vaage
  • Torben Krarup
  • Martti Nurmi
  • Bruno Larsson
  • Henrik Willumsen
  • Bo Johan Norlen

Detail Information

Publications10

  1. doi request reprint Urological aspects of the metabolic syndrome
    Jan Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Rosenborgsgatan 2, S 652 30 Karlstad, Sweden
    Nat Rev Urol 8:483-94. 2011
    ..Urologists need to be aware of the effect that the metabolic syndrome has on urological disorders and should transfer this knowledge to their patients...
  2. doi request reprint A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer
    J Hammarsten
    Department of Surgery, Section of Urology, Central Hospital, Karlstad, Sweden
    Cancer Epidemiol 34:574-9. 2010
    ..The present findings also seem to confirm that prostate cancer is a component of the metabolic syndrome. Finally, our data generate the hypothesis that the metabolic syndrome conceals early prostate cancer...
  3. ncbi request reprint Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, Halmstad, Sweden
    Blood Press 13:47-55. 2004
    ....
  4. ncbi request reprint Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Central Hospital, SE 30185 Halmstad, Sweden
    Eur J Cancer 41:2887-95. 2005
    ..Furthermore, our data suggest that the insulin level could be used as a marker of prostate cancer prognosis and tumour aggressiveness, regardless of the patient's prostate cancer stage, cancer grade and PSA level...
  5. doi request reprint Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
    J Hammarsten
    Department of Urology, Skaraborg Hospital, Skovde, Sweden
    Prostate Cancer Prostatic Dis 12:160-5. 2009
    ..Our findings also seem to confirm the metabolic syndrome hypothesis. The metabolic syndrome and its major endocrine aberration, hyperinsulinaemia, are possible primary events in BPH...
  6. ncbi request reprint Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer
    Jan Hammarsten
    Department of Urology, Halland, Varberg Hospital, Varberg, Sweden
    Scand J Urol Nephrol 36:330-8. 2002
    ..If the hypothesis is true, men with fast-growing BPH would have a more advanced clinical prostate cancer...
  7. ncbi request reprint Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia
    J Hammarsten
    Urological Section, Department of Surgery, Varberg Hospital, Varberg, Sweden
    Eur Urol 39:151-8. 2001
    ..To test the hypothesis of hyperinsulinaemia as a causal factor for the development of benign prostatic hyperplasia (BPH)...
  8. doi request reprint One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms
    Johan Stranne
    Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
    Scand J Urol Nephrol 43:199-205. 2009
    ..To investigate the prevalence of and restrictions in various parts of daily life due to lower urinary tract symptoms (LUTS) in an unselected Swedish male population...
  9. doi request reprint Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
    Per Olov Hedlund
    Department of Urology, Karolinska University Hospital Solna, Sweden
    Scand J Urol Nephrol 42:220-9. 2008
    ..The aim of the study was to compare anticancer efficacy and adverse events, especially cardiovascular events...
  10. ncbi request reprint Preoperative skin testing of materials used in surgical procedures
    Rosalie Hammarsten
    Central Operating Department, Varberg Hospital, Sweden
    AORN J 77:762-6, 769-71. 2003
    ..Skin reactions after preoperative skin testing occurred in 3% to 50% of patients with atopic or contact eczema, allergy, or asthma in their medical history...